Table 2: Biological and therapeutics features.
|
Frequency |
Percentage |
|
|
Complete Blood Count (N = 62) |
||
|
Normal |
36 |
58% |
|
Anemia |
11 |
17.7% |
|
Leukocytosis |
5 |
8.1% |
|
Leucopenia |
10 |
16.2% |
|
Erythrocyte Sedimentation Rate (N = 62) |
|
|
|
Normal |
35 |
56.5 |
|
High |
27 |
43.5 |
|
Toxoplasmosis serology (N = 67) |
|
|
|
Positive IgG |
50 |
74.6% |
|
Negative IgG |
17 |
25.4% |
|
Positive IgM |
3 |
4.5% |
|
Negative IgM |
64 |
95.5% |
|
Treatment |
|
|
|
Corticosteroid eye drops |
203 |
100% |
|
Specific treatment |
52 |
25.6% |
|
Corticosteroid peribulbar injection |
78 |
38.4% |
|
Oral corticosteroid |
24 |
11.8% |